269 related articles for article (PubMed ID: 11205256)
1. Reversal of multidrug resistance of tumor cells.
Szabó D; Keyzer H; Kaiser HE; Molnár J
Anticancer Res; 2000; 20(6B):4261-74. PubMed ID: 11205256
[TBL] [Abstract][Full Text] [Related]
2. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
3. Relevance of multidrug resistance in the age of targeted therapy.
Türk D; Szakács G
Curr Opin Drug Discov Devel; 2009 Mar; 12(2):246-52. PubMed ID: 19333870
[TBL] [Abstract][Full Text] [Related]
4. [Multidrug resistance of cancer cells mediated by ABC superfamily transporters].
Ueda K
Nihon Rinsho; 1997 May; 55(5):1024-9. PubMed ID: 9155147
[TBL] [Abstract][Full Text] [Related]
5. Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells.
Huang XC; Sun YL; Salim AA; Chen ZS; Capon RJ
Biochem Pharmacol; 2013 May; 85(9):1257-68. PubMed ID: 23415901
[TBL] [Abstract][Full Text] [Related]
6. Extensive contribution of the multidrug transporters P-glycoprotein and Mrp1 to basal drug resistance.
Allen JD; Brinkhuis RF; van Deemter L; Wijnholds J; Schinkel AH
Cancer Res; 2000 Oct; 60(20):5761-6. PubMed ID: 11059771
[TBL] [Abstract][Full Text] [Related]
7. From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance.
Litman T; Druley TE; Stein WD; Bates SE
Cell Mol Life Sci; 2001 Jun; 58(7):931-59. PubMed ID: 11497241
[TBL] [Abstract][Full Text] [Related]
8. [Drug resistance mediated by ABC transporters].
Yoshikawa M; Ito A; Ishikawa T; Ikegami Y
Gan To Kagaku Ryoho; 2004 Jan; 31(1):1-6. PubMed ID: 14750312
[TBL] [Abstract][Full Text] [Related]
9. Preface: the concept and consequences of multidrug resistance.
Sheps JA; Ling V
Pflugers Arch; 2007 Feb; 453(5):545-53. PubMed ID: 16862376
[TBL] [Abstract][Full Text] [Related]
10. Zafirlukast antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance.
Sun YL; Kathawala RJ; Singh S; Zheng K; Talele TT; Jiang WQ; Chen ZS
Anticancer Drugs; 2012 Sep; 23(8):865-73. PubMed ID: 22614107
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in P-glycoprotein-mediated multidrug resistance reversal mechanisms.
Li X; Li JP; Yuan HY; Gao X; Qu XJ; Xu WF; Tang W
Methods Find Exp Clin Pharmacol; 2007 Nov; 29(9):607-17. PubMed ID: 18193112
[TBL] [Abstract][Full Text] [Related]
12. Reversal of P-gp and BCRP-mediated MDR by tariquidar derivatives.
Li XQ; Wang L; Lei Y; Hu T; Zhang FL; Cho CH; To KK
Eur J Med Chem; 2015 Aug; 101():560-72. PubMed ID: 26197160
[TBL] [Abstract][Full Text] [Related]
13. Multidrug resistance/P-glycoprotein and breast cancer: review and meta-analysis.
Clarke R; Leonessa F; Trock B
Semin Oncol; 2005 Dec; 32(6 Suppl 7):S9-15. PubMed ID: 16360717
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological strategies for overcoming multidrug resistance.
Nobili S; Landini I; Giglioni B; Mini E
Curr Drug Targets; 2006 Jul; 7(7):861-79. PubMed ID: 16842217
[TBL] [Abstract][Full Text] [Related]
15. Computational classification models for predicting the interaction of drugs with P-glycoprotein and breast cancer resistance protein.
Erić S; Kalinić M; Ilić K; Zloh M
SAR QSAR Environ Res; 2014; 25(12):939-66. PubMed ID: 25435255
[TBL] [Abstract][Full Text] [Related]
16. Regulation and function of the multidrug resistance genes in liver.
Silverman JA; Thorgeirsson SS
Prog Liver Dis; 1995; 13():101-23. PubMed ID: 9224499
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and clinical aspects of efflux pump related resistance to anti-cancer drugs.
Aszalos A; Ross DD
Anticancer Res; 1998; 18(4C):2937-44. PubMed ID: 9713488
[TBL] [Abstract][Full Text] [Related]
18. Structural recognition of tubulysin B derivatives by multidrug resistance efflux transporters in human cancer cells.
Stark M; Assaraf YG
Oncotarget; 2017 Jul; 8(30):49973-49987. PubMed ID: 28637003
[TBL] [Abstract][Full Text] [Related]
19. Reversing agents for ATP-binding cassette drug transporters.
Lee CH
Methods Mol Biol; 2010; 596():325-40. PubMed ID: 19949930
[TBL] [Abstract][Full Text] [Related]
20. [Structures and functions of xenobiotic efflux pump P-glycoprotein and MRP--important molecular targets for cancer chemotherapy].
Ueda K
Gan To Kagaku Ryoho; 1997 Dec; 24(15):2190-5. PubMed ID: 9422060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
